Literature DB >> 29466147

A Framework for Ethical Payment to Research Participants.

Luke Gelinas1, Emily A Largent1, I Glenn Cohen1, Susan Kornetsky1, Barbara E Bierer1, Holly Fernandez Lynch1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29466147     DOI： 10.1056/NEJMsb1710591

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366.

Authors:  Karine Dubé; Lara Hosey; Kate Starr; Liz Barr; David Evans; Erin Hoffman; Danielle M Campbell; Jane Simoni; Jeremy Sugarman; John Sauceda; Brandon Brown; Karen L Diepstra; Catherine Godfrey; Daniel R Kuritzkes; David A Wohl; Rajesh Gandhi; Eileen Scully
Journal:  AIDS Res Hum Retroviruses       Date:  2020-04       Impact factor: 2.205

2.  Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants.

Authors:  Abhishek Pratap; Elias Chaibub Neto; Phil Snyder; Carl Stepnowsky; Noémie Elhadad; Daniel Grant; Matthew H Mohebbi; Sean Mooney; Christine Suver; John Wilbanks; Lara Mangravite; Patrick J Heagerty; Pat Areán; Larsson Omberg
Journal:  NPJ Digit Med       Date:  2020-02-17

3.  Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.

Authors:  Dustin C Krutsinger; Jacqueline McMahon; Alisa J Stephens-Shields; Brian Bayes; Steven Brooks; Brian L Hitsman; Su Fen Lubitz; Celine Reyes; Robert A Schnoll; S Ryan Greysen; Ashley Mercede; Mitesh S Patel; Catherine Reale; Fran Barg; Jason Karlawish; Daniel Polsky; Kevin G Volpp; Scott D Halpern
Journal:  Contemp Clin Trials       Date:  2018-11-08       Impact factor: 2.226

4.  Incentives and payments in pragmatic clinical trials: Scientific, ethical, and policy considerations.

Authors:  Andrew Garland; Kevin Weinfurt; Jeremy Sugarman
Journal:  Clin Trials       Date:  2021-12       Impact factor: 2.486

5.  You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research.

Authors:  Emily A Largent; Twisha Bhardwaj; Justin T Clapp; Olivia Saúl Sykes; Kristin Harkins; Joshua D Grill
Journal:  J Alzheimers Dis       Date:  2022-03-18       Impact factor: 4.160

6.  Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.

Authors:  Ryan W Huey; Goldy C George; Penny Phillips; Revenda White; Siqing Fu; Filip Janku; Daniel D Karp; Aung Naing; Sarina Piha-Paul; Vivek Subbiah; Apostolia M Tsimberidou; Shubham Pant; Timothy A Yap; Jordi Rodon; Funda Meric-Bernstam; Ya-Chen Tina Shih; David S Hong
Journal:  Oncologist       Date:  2021-04-21

7.  Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study.

Authors:  Karen L Diepstra; Liz Barr; David Palm; Evelyn Hogg; Katie R Mollan; Laney Henley; Angela M Stover; Jane M Simoni; Jeremy Sugarman; Brandon Brown; John A Sauceda; Steven Deeks; Lawrence Fox; Rajesh T Gandhi; Davey Smith; Jonathan Z Li; Karine Dubé
Journal:  AIDS Res Hum Retroviruses       Date:  2021-02-16       Impact factor: 1.723

Review 8.  Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy.

Authors:  Euzebiusz Jamrozik; Michael J Selgelid
Journal:  J Med Ethics       Date:  2020-05-07       Impact factor: 2.903

9.  Are Payments to Human Research Subjects Ethically Suspect?

Authors:  David B Resnik
Journal:  J Clin Res Best Pract       Date:  2019-06

10.  Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.

Authors:  Jill A Fisher; Lisa McManus; Marci D Cottingham; Julianne M Kalbaugh; Megan M Wood; Torin Monahan; Rebecca L Walker
Journal:  PLoS Med       Date:  2018-11-20       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.